A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles

Erratum

A Protective Allergy Vaccine Based on CpG- and Protamine-Containing

PLGA Microparticles

Julia M. Martı´nez Go´mez,1Stefan Fischer,2Noe`mi Csaba,2Thomas M. Ku¨ndig,1Hans P. Merkle,2 Bruno Gander,2and Pa˚l Johansen1,3

Published online July 10, 2007

The following errors were published in this article:

The first author_s family name was incorrectly coded as Go´mez. Therefore, an online search for the article using the first author_s family name—Martı´nez Go´mez—would not work. The first author_s family name has been correctly coded as Martı´nez Go´mez in this erratum.

The corresponding author_s email address was listed as [email protected]

The correct email address includes a dot after the first 3 characters: [email protected]

0724-8741/08/0300-0710/0 # 2007 Springer Science + Business Media, LLC 710

Pharmaceutical Research, Vol. 25, No. 3, March 2008 (#₂₀₀₇₎

DOI: 10.1007/s11095-007-9386-1

1_{Unit for Experimental Immunotherapy, Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091, Zurich,}

Switzerland.

2_{Drug Delivery and Formulation, Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.} 3_{To whom correspondence should be addressed. (e-mail: [email protected])}